Henry Ford Health System
Clinical trials sponsored by Henry Ford Health System, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a common Anti-Inflammatory replace opioids after hip surgery? Results expected Sep 2026 (estimated)
- New study aims to cut opioid use after broken bone surgery Results expected Sep 2026 (estimated)
- Can a new Long-Acting injection replace opioids after knee surgery? Results expected Oct 2026 (estimated)
- New combo therapy targets hard-to-treat GI cancers Results expected Dec 2026 (estimated)
- Hip replacement patients may use fewer opioids with a simple change Results expected Dec 2026 (estimated)
-
Could a common vitamin speed stroke recovery?
Disease control Stopped earlyThis phase 2 trial tests whether extended-release niacin, a form of vitamin B3, can safely help people recover after an ischemic stroke. Researchers will give participants either niacin or a placebo daily, starting within a week of their stroke. The study tracks safety and measur…
Phase 2 • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Rearranging the treatment timeline: could a new sequence of chemo and radiation spare rectal cancer patients from major surgery?
Disease control Stopped earlyThis trial is testing whether giving chemotherapy before the standard combination of chemo and radiation for rectal cancer could allow some patients to have a minor surgical procedure instead of a major one. The study enrolls adults with stage T2-T3 rectal cancer. The goal is to …
Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Rectal cancer: could a 'Watch and Wait' strategy spare patients from major surgery?
Disease control Stopped earlyThis trial is testing whether a 'watchful waiting' approach after chemotherapy and radiation can safely avoid radical surgery in people with a certain type of rectal cancer. Participants receive chemotherapy (FOLFOX) followed by chemo-radiation, and those whose tumors completely …
Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
A simple breath test could spot mesothelioma years earlier
Diagnosis Stopped earlyThis study explores whether chemicals in a person's breath, called volatile organic compounds, can serve as early warning signs of pleural mesothelioma in people who have been exposed to asbestos. Researchers will also check if a blood marker, SMRP, adds to the breath test's accu…
Sponsor: Henry Ford Health System • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
New heart stress test aims to diagnose blockages without radiation
Diagnosis Stopped earlyThis study tested a new stress echocardiography method using regadenoson and atropine to diagnose coronary artery disease. It involved 45 adults scheduled for cardiac catheterization. The goal was to see if this faster, radiation-free approach could accurately detect significant …
Sponsor: Henry Ford Health System • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
Thumb arthritis surgery showdown: old vs. new technique
Symptom relief Stopped earlyThis study compared two surgical treatments for thumb arthritis at the base of the thumb. The standard surgery removes a small bone and fills the space with a tendon graft. The newer method uses a special tape to hold the thumb bone in place. The study was stopped early and inclu…
Sponsor: Henry Ford Health System • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Methadone tested to shorten time on breathing machines in ICU
Symptom relief Stopped earlyThis study tested whether giving methadone to ICU patients on breathing machines could help them get off the ventilator faster. Patients who needed strong painkillers were given either methadone or a placebo. The trial was stopped early and only included 9 people, so no firm conc…
Phase 4 • Sponsor: Henry Ford Health System • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC